Free Trial
NASDAQ:BBNX

Beta Bionics (BBNX) Stock Price, News & Analysis

Beta Bionics logo
$19.08 -0.47 (-2.40%)
As of 06/6/2025 04:00 PM Eastern

About Beta Bionics Stock (NASDAQ:BBNX)

Key Stats

Today's Range
$18.35
$20.19
50-Day Range
$9.71
$19.55
52-Week Range
$8.89
$24.50
Volume
583,609 shs
Average Volume
503,190 shs
Market Capitalization
$827.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.13
Consensus Rating
Moderate Buy

Company Overview

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Receive BBNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beta Bionics and its competitors with MarketBeat's FREE daily newsletter.

BBNX Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
See More Headlines

BBNX Stock Analysis - Frequently Asked Questions

Beta Bionics' stock was trading at $23.81 at the start of the year. Since then, BBNX shares have decreased by 19.9% and is now trading at $19.08.
View the best growth stocks for 2025 here
.

Beta Bionics, Inc. (NASDAQ:BBNX) issued its quarterly earnings data on Tuesday, May, 6th. The company reported ($0.52) EPS for the quarter, missing the consensus estimate of ($0.51) by $0.01.
Read the conference call transcript
.

Beta Bionics (BBNX) raised $204 million in an initial public offering on Thursday, January 30th 2025. The company issued 12,000,000 shares at a price of $17.00 per share.

Beta Bionics' lock-up period expires on Tuesday, July 29th. Beta Bionics had issued 12,000,000 shares in its initial public offering on January 30th. The total size of the offering was $204,000,000 based on an initial share price of $17.00. After the expiration of Beta Bionics' lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.

Beta Bionics' top institutional investors include Eventide Asset Management LLC (11.37%), Wellington Management Group LLP (9.00%), Sands Capital Ventures LLC (7.16%) and Omega Fund Management LLC (4.59%). Insiders that own company stock include Hadley Harbor Aggre Wellington, Mike Mensinger, Steven Jon Russell, Stephen Feider and Mark Hopman.
View institutional ownership trends
.

Shares of BBNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/06/2025
Today
6/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BBNX
Previous Symbol
NASDAQ:BBNX
Web
N/A
Fax
N/A
Employees
294
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$23.13
High Stock Price Target
$30.00
Low Stock Price Target
$16.00
Potential Upside/Downside
+21.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.73
Research Coverage
11 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$69.83 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$827.23 million
Optionable
N/A
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:BBNX) was last updated on 6/8/2025 by MarketBeat.com Staff
From Our Partners